Bottom line
What is QEVAX's expense ratio?
QEVAX's expense ratio is 2.39%, or about $239 a year on every $10,000 invested. That is more expensive than 96% of large blend funds we track (median 0.83%). Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Oct 28, 2026
QEVAX fee table
| Net expense ratio | 2.39% |
|---|---|
| Gross expense ratio | 2.39% |
| Management fee | 1% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.26% |
| Acquired fund fees | 0.13% |
Source: Fund prospectus fee table, filed Oct 28, 2026
What QEVAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| QEVAX | $242 | $745 | $1,275 | $2,726 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.39% expense ratio costs roughly $117,500 in lost growth, versus about $46,700 for the median large blend fund (0.83%).